Hi, this is Sean Salai, culture reporter at The Washington Times.
We are out at the 53rd National March for Life, where we are interviewing pro-life leaders.
[BRADLEY LICHTER] Good morning, Sean. I’m Jennie Bradley Lichter, president of the March for Life.
[SALAI] This is your first year at the March for Life. In the last few years since the Dobbs ruling, we’ve had a number of changes in the pro-life landscape, with the issue being returned to the states. What do you want to see from the Trump administration this year in terms of federal policy?
[BRADLEY LICHTER] Well, we saw some great pro-life policies just announced yesterday by the president and his team, including a couple of things that I had worked on related issues when I was a policy official in the first term, so I am absolutely thrilled and very grateful to see them stopping the use of aborted baby body parts for scientific research. They are investigating Planned Parenthood’s illegal receipt of COVID relief funds through the Small Business Administration. And of course, they are expanding the iconic Mexico City policy. So we’re grateful for that and for all of the other great pro-life policy efforts in the last year.
Of course, there is more work to do as well. So we are continuing to call on the administration to continue the close look that they have indicated that they are in the middle of working on at Mifepristone and its great dangers to American women. And we’re looking forward to seeing the outcome of that study and we fully expect that this administration will be limiting the availability of Mifepristone.
[SALAI] And the Trump administration’s FDA has promised a review of the side effects of Mifepristone that we are currently awaiting. The administration says it takes time to produce these gold standard science reviews.
For more of our coverage of the March for Life, please visit washingtontimes.com.
